[HTML][HTML] A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders
DA Geier, JK Kern, G Davis, PG King… - … medical journal of …, 2011 - ncbi.nlm.nih.gov
DA Geier, JK Kern, G Davis, PG King, JB Adams, JL Young, MR Geier
Medical science monitor: international medical journal of experimental …, 2011•ncbi.nlm.nih.govA prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum
disorders - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List Med Sci Monit v.17(6); 2011
PMC3539542 Other Formats PubReader PDF (399K) Actions Cite Collections Share Permalink
Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal …
disorders - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List Med Sci Monit v.17(6); 2011
PMC3539542 Other Formats PubReader PDF (399K) Actions Cite Collections Share Permalink
Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal …
Summary
Background
L-carnitine was proposed as a potential treatment for patients diagnosed with an autism spectrum disorder to improve mitochondrial dysfunction, but no prior randomized controlled trials have been conducted.
ncbi.nlm.nih.gov
